Skip to main content
Cancer Management and Research logoLink to Cancer Management and Research
. 2021 Sep 10;13:7055–7056. doi: 10.2147/CMAR.S338286

Assessment of Potential Prognostic Value of Peroxiredoxin 1 in Oral Squamous Cell Carcinoma [Corrigendum]

PMCID: PMC8439385  PMID: 34531683

Shen Y, Xu H, Li L, et al. Cancer Manag Res. 2021;13:5725–5737.

The authors have advised due to an error at the time of figure assembly, the legend shown in Figure 7D was incorrectly written as AUC at 1 years, AUC at 2 years and AUC at 3 years, it should read AUC at 1 years, AUC at 3 years and AUC at 5 years, respectively.

Figure 7.

Figure 7

The establishment of a nomogram that can predict the 1-, 3-, and 5-year survival rates of patients with OSCC. (A) Cox proportional hazards regression analysis for PRDX1 and clinical features; (B) A nomogram containing Tumor stage, N stage and PRDX1 level; (C and D) The accuracy of nomogram in the TCGA cohort and testing cohort was verified by the ROC curve.

The correct Figure 7 is shown below.

The authors apologize for this error and advise it does not affect the scientific conclusions of the paper.


Articles from Cancer Management and Research are provided here courtesy of Dove Press

RESOURCES